SCHEMBL2496147

SCHEMBL2496147

COC(=O)[C@H](C)Cc1cccc(O)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NLRP3 Q96P20 1/20 0.50
SPR P35270 1/20 0.48
EGFR P00533 1/20 0.47
SLC7A5 Q01650 1/20 0.44
ALDH1A1 P00352 1/20 0.43
THRB P10828 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
HSD17B10 Q99714 1/20 0.43
GRIA2 P42262 1/20 0.43
GABRA1 P14867 1/20 0.43
GABRG2 P18507 1/20 0.43
GABRB3 P28472 1/20 0.43
GABRA3 P34903 1/20 0.43
GABRA2 P47869 1/20 0.43
GABRB2 P47870 1/20 0.43
ESR1 P03372 1/20 0.43
ESR2 Q92731 1/20 0.43
ESRRB O95718 1/20 0.43
MEN1 O00255 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2500604 1.00 NLRP3 (0.50) NLRP3SPREGFRSLC7A5ALDH1A1
SCHEMBL27810401 1.00 NLRP3 (0.50) NLRP3SPREGFRSLC7A5ALDH1A1
SCHEMBL12191879 0.86 L3MBTL1 (0.43) NLRP3ALDH1A1GRIA2MAPK1
SCHEMBL2496064 0.86 L3MBTL1 (0.43) NLRP3ALDH1A1GRIA2MAPK1
SCHEMBL12191878 0.86 L3MBTL1 (0.43) NLRP3ALDH1A1GRIA2MAPK1
SCHEMBL6384666 0.85 NLRP3 (0.51) NLRP3SPREGFRGRIA2GABRA1
SCHEMBL8802162 0.84 ALDH1A1 (0.47) SLC7A5ALDH1A1THRBCYP2C9CYP2C19
SCHEMBL6028187 0.84 TAAR1 (0.54) SLC7A5MEN1KMT2A
SCHEMBL27705535 0.84 NLRP3 (0.50) NLRP3SPREGFRGRIA2GABRA1
SCHEMBL13085683 0.84 NLRP3 (0.50) NLRP3SPREGFRGRIA2GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8030354-B2 2-(5,5-Dimethylcyclopent-1-enyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane; metabolic disorders such as type II diabetes AMGEN INC. (US) 2011-10-04 US disclosed
CN-102083783-A Substituted biphenyl GPR40 modulators AMGEN INC 2011-06-01 CN disclosed